Natalizumab-induced thrombocytopenia: A case report

  • Amirreza Azimi Multiple Sclerosis Research Center, Tehran University of Medical Sciences, Tehran, Iran
  • Zohreh Abna Multiple Sclerosis Research Center, Tehran University of Medical Sciences, Tehran, Iran
  • Fereshteh Ghadiri Multiple Sclerosis Research Center, Tehran University of Medical Sciences, Tehran, Iran
  • Farzad Mehrabi Multiple Sclerosis Research Center, Tehran University of Medical Sciences, Tehran, Iran
DOI: https://doi.org/10.18502/cjn.v21i1.9363
Keywords: Drug; Natalizumab; Immune Thrombocytopenia; Multiple Sclerosis; Therapeutics

Abstract

The article's abstract is not available.

Published
2022-05-01
Issue
Volume (21) issue (1)
Section
Articles